Ampio Pharmaceuticals, Inc.
AMPE · OTC
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | |
|---|---|---|---|---|
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Cost of Goods Sold | $0 | $2 | $1 | $1 |
| Gross Profit | -$0 | -$2 | -$1 | -$1 |
| % Margin | – | – | – | – |
| R&D Expenses | $2 | $9 | $12 | $9 |
| G&A Expenses | $7 | $11 | $9 | $7 |
| SG&A Expenses | $7 | $11 | $9 | $7 |
| Sales & Mktg Exp. | -$0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | -$2 | -$1 | $0 |
| Operating Expenses | $9 | $18 | $19 | $16 |
| Operating Income | -$10 | -$20 | -$21 | -$16 |
| % Margin | – | – | – | – |
| Other Income/Exp. Net | $1 | $4 | $3 | -$0 |
| Pre-Tax Income | -$9 | -$16 | -$17 | -$16 |
| Tax Expense | $0 | -$8 | -$5 | $1 |
| Net Income | -$9 | -$16 | -$17 | -$16 |
| % Margin | – | – | – | – |
| EPS | -10.67 | -11.24 | -18.79 | -28.63 |
| % Growth | 5.1% | 40.2% | 34.4% | – |
| EPS Diluted | -10.66 | -29.32 | -18.59 | -27.59 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $0 | $0 | $0 | $0 |
| Depreciation & Amortization | $0 | $1 | $1 | $1 |
| EBITDA | -$8 | -$23 | -$16 | -$15 |
| % Margin | – | – | – | – |